The global next-generation neurofeedback device market is projected to increase from USD 352.5 million in 2025 to USD 1,768.2 million by 2035, registering a compound annual growth rate (CAGR) of 17.5%, according to Future Market Insights (FMI). The forecast reflects growing interest in non-invasive brain-training technologies, digital neuroscience, and personalized approaches to cognitive and behavioral health.

Next-generation neurofeedback devices measure brain activity and provide feedback intended to help users learn to regulate specific brainwave patterns. Advances in wearable sensors, artificial intelligence (AI), and connected software are expanding the range of potential applications, from clinical neurofeedback programs to cognitive training and home-based wellness systems.

👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7957

Commercial adoption will depend on clinical evidence, ease of use, practitioner training, and clear communication about the conditions for which individual devices have been evaluated. The market spans several applications, including attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, epilepsy, insomnia, and other conditions.

Key Market Highlights

· Market size (2025): USD 352.5 million

· Forecast value (2035): USD 1,768.2 million

· Forecast CAGR (2025–2035): 17.5%

· Calculated incremental market opportunity: USD 1,415.7 million

· Leading product type: Brand-name neurofeedback systems, with 51.6% share in 2025

· Leading application: ADHD, with 42.8% share in 2025

· Leading end user: Hospitals, with 45.0% share in 2025

· Fastest-growing profiled country: China, at 23.6% CAGR

· Key companies: Neurable, Looxid Labs, Neurotech International Ltd., ANT Neuro, BrainMaster Technologies Inc., Neurogen Ltd., NeurOptimal, and EEG Info

Brand-Name Neurofeedback Systems Lead the Product Segment

Brand-name neurofeedback systems are projected to account for 51.6% of market revenue in 2025, making them the leading product category in FMI's analysis.

Established product recognition, technical support, training resources, and familiarity among practitioners can influence purchasing decisions in a market where devices require consistent setup and interpretation. Integration with sensors and software can also help users monitor brainwave activity and review feedback during training sessions.

The product category includes systems used in clinical and other structured settings. As manufacturers develop more accessible interfaces and automated feedback features, buyers will continue to assess device usability, data quality, reliability, and the evidence supporting each intended application.

The report also identifies 3D neurofeedback systems as a distinct product category. These technologies form part of the market's broader development toward more sophisticated feedback environments and brain-training tools.

ADHD Represents the Largest Application Segment

ADHD is expected to account for 42.8% of application revenue in 2025. Neurofeedback is being explored as a non-invasive approach to training users to regulate selected patterns of brain activity, making it relevant to research and clinical interest in attention and behavioral self-regulation.

Demand is influenced by awareness of behavioral health interventions, interest in non-pharmacological approaches, and the availability of structured programs delivered by trained professionals. However, neurofeedback should not be presented as a universally effective replacement for established ADHD treatments. Its suitability and evidence base depend on the specific protocol, patient, and clinical context.

Other applications covered by FMI include anxiety, depression, epilepsy, insomnia, drug addiction, schizophrenia, and other conditions. These use cases have different clinical requirements, and evidence supporting one application cannot automatically be generalized to another.

Hospitals Remain the Leading End-User Category

Hospitals are forecast to account for 45.0% of market revenue in 2025. Their access to specialist staff, clinical infrastructure, and structured treatment environments supports the use of neurofeedback systems in selected care and research settings.

Hospital adoption may also benefit from the ability to integrate neurofeedback sessions with assessment and follow-up. Procurement decisions, however, depend on available evidence, staff expertise, device requirements, patient suitability, and the resources needed to deliver repeated sessions.

FMI also identifies physician offices, clinics, and ambulatory surgical centers as end-user categories. As device formats and software evolve, providers will assess whether systems fit their workflows and whether outcomes can be measured consistently.

Country-Level Growth Outlook

· China leads the country outlook with a projected CAGR of 23.6%. Its forecast places it at the forefront of the markets profiled by FMI, although the rate should be interpreted as a market projection rather than a measure of clinical adoption or treatment effectiveness.

· India, at 21.9%, also records a high forecast growth rate. Interest in digital health and non-invasive approaches may create opportunities for suppliers, subject to affordability, practitioner availability, and the development of suitable delivery models.

· Germany is projected to grow at 20.1%, followed by France at 18.4%. Both markets offer potential for neurofeedback providers, while clinical evidence, professional training, and applicable medical-device requirements remain relevant to adoption.

· The United Kingdom is forecast to expand at 16.6%. The United States is projected to grow at 14.9%; FMI estimates its market at USD 131.7 million in 2025, increasing to USD 527.0 million by 2035. Brazil, at 13.1%, has the lowest CAGR among the countries listed in the report, but still represents a growing market opportunity.

Market Drivers, Restraints, and Opportunities

Drivers: Digital neuroscience and demand for non-invasive interventions

Interest in brain health and personalized behavioral interventions is encouraging the development of technologies that measure physiological signals and provide real-time feedback. Neurofeedback devices can combine sensors, signal-processing software, and visual or auditory cues to support structured training.

Wearable formats and connected platforms may make some systems easier to deploy beyond specialist laboratories. These developments can expand potential use cases, provided device performance and intended use are appropriately established.

Restraints: Clinical evidence and user expertise

Market expansion faces challenges related to evidence quality, protocol standardization, practitioner training, and the need for repeated sessions. Different systems may use different sensors, feedback methods, and measures of success, making direct comparisons difficult.

Buyers must also distinguish between products intended for wellness or cognitive training and devices marketed for medical purposes. Claims about diagnosis or treatment require evidence appropriate to the intended use and compliance with applicable regulatory requirements.

Opportunities: Home-based and connected neurofeedback

Home-use systems and telehealth-supported programs offer potential routes to wider access. Remote platforms may allow users to complete sessions outside clinical facilities while enabling practitioners to monitor participation and review selected performance measures.

Successful implementation will depend on usability, appropriate supervision, data privacy, and safeguards for users who may need clinical assessment rather than self-directed training. Companies that clearly define intended use and provide reliable technical support may be better positioned to address different customer needs.

Access Full Report: https://www.futuremarketinsights.com/reports/next-generation-neurofeedback-device-market

Competitive Landscape

The market includes specialized neurotechnology businesses and manufacturers of neurofeedback systems. Competition can center on sensor design, feedback quality, software capabilities, ease of use, technical support, and the evidence available for specific applications.

Key companies identified in FMI's report include:

· Neurable

· Looxid Labs

· Neurotech International Ltd.

· ANT Neuro

· BrainMaster Technologies Inc.

· Neurogen Ltd.

· NeurOptimal

· EEG Info

As the category develops, vendors will need to differentiate their products through practical usability, transparent performance information, and evidence appropriate to their intended markets. Partnerships with clinicians and research institutions may also help manufacturers evaluate systems and refine their applications.

Frequently Asked Questions

1. How large is the next-generation neurofeedback device market?

FMI estimates the market at USD 352.5 million in 2025 and projects it to reach USD 1,768.2 million by 2035.

2. What is the expected CAGR?

The market is forecast to grow at a CAGR of 17.5% between 2025 and 2035.

3. Which product type leads the market?

Brand-name neurofeedback systems are projected to account for 51.6% of market revenue in 2025.

4. Which application represents the largest share?

ADHD is forecast to account for 42.8% of application revenue in 2025.

5. Which end-user category leads the market?

Hospitals are expected to represent 45.0% of market revenue in 2025.

6. Which country is projected to grow fastest?

China leads FMI's country forecasts at 23.6% CAGR, followed by India at 21.9% and Germany at 20.1%.

Related Reports:

· https://www.openpr.com/news/4663069/united-kingdom-glioblastoma-tumor-treating-fields-therapy

· https://www.openpr.com/news/4663071/federated-learning-drug-discovery-market-to-reach-usd-1-90

· https://www.openpr.com/news/4663073/mechanical-thrombectomy-system-market-to-reach-usd-1-97-billion

About Future Market Insights (FMI)

Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales – [email protected]